Research offers the opportunity for our staff and patients to become involved in novel and innovative approaches to psychiatric care. By partnering with the biotechnology community, industry, and academia-based research programs, Pine Rest Christian Mental Health Services is also established as an institution dedicated to advancing the diagnosis and treatment of psychiatric disorders.
“When considering potential research, we look for studies that: address an unmet clinical need, investigate a new/novel treatment approach, aid in early diagnosis or response to treatment, and explore genetics and personalized medicine,” says Eric Achtyes, MD, Staff Psychiatrist, Pine Rest CMHS, Interim Director, MSU Division of Psychiatry and Behavioral Medicine.
Pine Rest is currently involved in the following clinical trials. If you are interested in study participation, our research staff can be reached at 616-222-4592 or research@pinerest.org.
Open to enrollment
Pine Rest does not currently have any research studies open to enrollment.
Closed to enrollment but in progress
Pharmacogenomics in the selection of antidepressants
(Pilot Study)
Key question: Can genetic information lead to a more rapid selection of safe and effective antidepressant medications?
Principal Investigator: Kevin Furmaga, PharmD, BCPP, Clinical Psychopharmacology Specialist
Link to trial posted on clinicaltrials.gov
Field Testing of the Computerized Adaptive Testing-Depression Inventory (CAT-DI)
Key Question: Can a combination of item response theory and computerized adaptive testing measurement be used to accurately detect the probability of depression, bipolar or anxiety disorders, therefore, reducing the burden of research and clinical assessments?
Principal Investigator: Scott Halstead, PhD, Neuropsychologist, Corporate Director of the Pine Rest Professional Practice Group
Short Term Efficacy and Cognitive Side Effects of Acute Electroconvulsive Therapy for Agitation and Aggression in Dementia (A Prospective Study)
Key question: Do patients with dementia receiving standard care vs. Electroconvulsive Therapy (ECT) differ in reduction of aggression and agitation symptom severity and changes in cognition pre- and post-treatment?
Principal Investigator: Jack Mahdasian, MD, Staff Psychiatrist, Older Adult Unit
